Cognitive decline is associated with gene expression changes in the brain, but the transcriptional mechanisms underlying memory impairments in cognitive disorders, such as Alzheimer's disease (AD), are largely unknown. Here, we aimed to elucidate relevant mechanisms responsible for transcriptional changes underlying early memory loss in AD by examining pathological, behavioral, and transcriptomic changes in control and mutant ␤-amyloid precursor protein (APP Sw,Ind ) transgenic mice during aging. Genome-wide transcriptome analysis using mouse microarrays revealed deregulation of a gene network related with neurotransmission, synaptic plasticity, and learning/memory in the hippocampus of APP Sw,Ind miceafterspatialmemorytraining.Specifically,APP Sw,Ind miceshowchangesonacAMP-responsiveelementbindingprotein(CREB)-regulated transcriptional program dependent on the CREB-regulated transcription coactivator-1 (Crtc1). Interestingly, synaptic activity and spatial memory induces Crtc1 dephosphorylation (Ser151), nuclear translocation, and Crtc1-dependent transcription in the hippocampus, and these events are impaired in APP Sw,Ind mice at early pathological and cognitive decline stages. CRTC1-dependent genes and CRTC1 levels are reduced in human hippocampus at intermediate Braak III/IV pathological stages. Importantly, adeno-associated viral-mediated Crtc1 overexpression in the hippocampus efficiently reverses A␤-induced spatial learning and memory deficits by restoring a specific subset of Crtc1 target genes. Our results reveal a critical role of Crtc1-dependent transcription on spatial memory formation and provide the first evidence that targeting brain transcriptome reverses memory loss in AD.
Introduction
Alzheimer's disease (AD), the most common cause of dementia, is characterized pathologically by abnormal accumulation of ␤-amyloid (A␤) peptides, hyperphosphorylated tau and synapse dysfunction in the brain. The earliest cognitive symptoms of the disease are temporally associated with progression of tau and amyloid pathologies from the entorhinal cortex and hippocampus to associative and temporal cortical areas (Braak et al., 2006) . Memory impairments in AD transgenic mouse models are evident before accumulation of amyloid plaques (Oddo et al., 2003; Saura et al., 2005) suggesting that events downstream of A␤ contribute to synaptic changes early in the disease process. Among these events, transcriptome changes affecting cell signaling, metabolic, inflammation and neurotransmission pathways precede neuropathology in AD brains (Blalock et al., 2004; Bossers et al., 2010; Twine et al., 2011) . This raises the possibility that deregulation of mechanisms controlling brain transcriptome may underlie memory loss at early AD stages.
Activity-dependent gene transcription is essential for longlasting plastic changes in neuronal circuits encoding memory. cAMP-responsive element binding protein (CREB)-dependent transcription, which mediates neuronal excitability, synaptic plasticity, and long-lasting memory in the hippocampus (Lee and Silva, 2009) , depends on the transcriptional coactivator CRTC1 (or mouse Crtc1) (Conkright et al., 2003b) . In response to synaptic activity, Crtc1 translocates from the cytosol to the nucleus to increase CREB binding to specific gene promoters (Altarejos et al., 2008; España et al., 2010b; Ch'ng et al., 2012) . Recent evidences suggest that A␤ negatively affect hippocampal synaptic plasticity, memory and synapse loss by deregulating cAMP/Ca 2ϩ -mediated CREB signaling (Vitolo et al., 2002; Smith et al., 2009; España et al., 2010b) . Consistently, CREB-signaling activation ameliorates learn-ing and/or memory deficits in transgenic AD mouse models (Gong et al., 2004; Caccamo et al., 2010; Yiu et al., 2011) . These results suggest that disruption of CREB signaling may contribute to memory deficits in AD (Saura and Valero, 2011) , but the specific CREBdependent gene programs that mediate early synaptic dysfunction and memory loss in AD are unknown. A better understanding of these mechanisms is crucial for elucidating new signaling pathways for drug discovery in cognitive disorders.
To investigate the molecular mechanisms responsible for transcriptome changes during the progression of AD, we performed extensive pathological, behavioral, transcriptional, and biochemical analyses in WT and APP transgenic mice at 2-18 months of age (Mucke et al., 2000) . Genome-wide transcriptome analyses were performed in naive and memory trained APP Sw,Ind transgenic mice at initial pathological and cognitive decline stages. Microarray and bioinformatic enrichment analyses revealed a set of CREB-dependent genes involved in synaptic function and plasticity deregulated in the hippocampus of APP Sw,Ind transgenic mice specifically after memory training. These transcriptional changes were associated with Crtc1 dysfunction but not CREB changes. Crtc1 overexpression in the hippocampus efficiently reversed transcriptome and spatial learning and memory deficits in APP Sw,Ind mice, suggesting that enhancing Crtc1 function may provide therapeutic benefits for transcriptome and memory deficits at early AD stages.
Materials and Methods
Transgenic mice and human samples. APP Sw,Ind transgenic mice (line J9) expressing human APP 695 harboring the FAD-linked Swedish (K670N/ M671L) and Indiana (V717F) mutations under the neuronal PDGF␤ promoter were obtained by crossing APP Sw,Ind to nontransgenic (WT) mice. Mice used in this study were age-matched male littermate control and APP Sw,Ind mice (C57BL/6 background). Human brain samples were obtained from brain banks of Hospital de Bellvitge (Universitat de Barcelona, Spain) and Fundació n CIEN (Instituto de Salud Carlos III, Spain). Brains samples were matched as closely as possible for sex, age and postmortem interval. Neuropathology was classified according to Braak staging for neurofibrillary tangles and neuritic plaques (Braak et al., 2006) . Experimental procedures were conducted according to the Animal and Human Ethical Committee of the Universitat Autò noma de Barcelona (protocol CEEAH 1783, Generalitat Catalunya 6381) following the European Union guidelines.
Viral constructs and transcriptional assays. Lentiviral Crtc1 shRNAs were generated by transfecting pLVTHM containing mouse Crtc1 or scramble ShRNA, pSPAX2 and pM2G vectors in HEK293T cells as described previously (España et al., 2010b) . Adeno-associated virus (AAV) AAV2/10-Crtc1-myc containing the AAV2 genome into AAV10 packing vectors and under the chicken ␤-actin promoter was generated by subcloning pcDNA3-Crtc1-myc (Kovács et al., 2007) into pVAX1 (Invitrogene) and pGV-IRES2-GFP vectors. AAV were generated by transfecting HEK293T cells with AAV2 recombinant, pRepAAV2/CapAAV10, and pXX6 vectors. For transcriptional assays, hippocampal neurons were infected at 3 DIV with scramble or Crtc1 shRNA lentivirus (2 transducing units/cell) or AAV2/10-Crtc1 or AAV2/10-GFP virus (1 ϫ 10 5 gc/cell). Neurons (10 DIV) were transfected with pCRE-luc (0.5 g; Stratagene) and TK renilla (0.25 g; Promega) plasmids using LipofectAMINE 2000 for 24 h before stimulation (FSK/KCl) for 4 h and analyzed with the dual-luciferase activity assay (Promega) in a Synergy HT luminometer (Bio-Tek; España et al., 2010b) .
ChIP analysis. Chromatin immunoprecipitation (ChIP) was performed as described previously (Dahl and Collas, 2008; España et al., 2010b) . Neurons (12-14 DIV) were treated with vehicle or FSK (20 M) and KCl (30 mM) for 30 min. Cells were crosslinked with 1% formaldehyde, lysed in ChIP buffer (50 mM Tris-HCl, pH 8.1, 100 mM NaCl, 5 mM EDTA, 1% SDS, 0,1% Na deoxycholate, and protease/phosphatase inhibitors) and sonicated. DNA (2.5 g) immunoprecipitations were performed overnight in diluted ChIP buffer (0.1% SDS, 1.1% Triton X-100) with rabbit CRTC1 and CREB antibodies or irrelevant IgGs (Cell Signaling Technology). Immunoprecipitated DNA was decrosslinked and amplified by real-time PCR using specific primers for CRE-containing promoter sequences of specific genes.
Behavioral studies and viral injections. The Morris water maze (MWM) was performed in 3 d handled mice in a circular pool (90 cm diameter; 6.5 cm hidden platform) for three or five consecutive days (4 trials daily; 60 s per trial; España et al., 2010a) . Mice were tested for memory retention (probe trial) 2.5 h after training on day five, and they were killed 30 min after training. We selected this time to get a measure of memory retention while achieving a maximum peak of gene expression, which occurs ϳ0.5-2 h after spatial training (Guzowski et al., 2001) . The swimming group moved freely in the maze without platform for 5 d and mice were killed 30 min after a simulated probe trial. For viral injections, 6-monthold mice (n ϭ 8 mice/group) were anesthetized with isofluorane and placed in a stereotaxic platform (Kopf). The injection coordinates for the hippocampus were as follows: anterior 0.2 caudal to bregma; 0.18 lateral to bregma; depth 0.2 ventral to dural surface. AAV2/10-GFP or -Crtc1 viral stocks (3 l; 5.1 ϫ 10 11 gc/ml; 0.5 l/min) were injected bilaterally into the hippocampus. Three weeks after AAV injection mice were tested in the water maze (120 cm circular pool; 11 cm platform) for 5 d (6 trials daily; 60 s per trial), tested in a probe trial 2.5 h after training, killed, and dissected. Importantly, both maze setups lead to similar values of escape latencies during spatial training and memory retention in the probe trial test in WT and APP Sw,Ind mice (compare Figs. 1C, 4D) . In all cases, spatial learning and memory parameters were analyzed with SMART software (PanLab; España et al., 2010a) .
Biochemical analysis. For biochemical analysis, naive and trained mice were killed 30 min after training by cervical dislocation and whole hippocampus dissected out and immediately frozen. Tissue was lysed in cold-lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 0.5% Triton X-100, 1% NP-40, 0.1% SDS, 1 mM Na 3 VO 4 , 50 mM NaF, 1 mM PMSF) containing protease and phosphatase inhibitors (Roche). For nuclear fractionation mouse forebrains were freshly dissected, gently homogenized in ice-cold sucrose buffer A (10 mM HEPES, pH 7.5, 200 mM sucrose, 1.5 mM MgCl 2 , 10 mM KCl, protease/phosphatase inhibitors) and centrifuged (1500 ϫ g, 15 min). The pellet was homogenized in 1.6 M sucrose buffer, fractionated in 2.2-1.4 M sucrose gradients (100,000 ϫ g, 35 min, 4°C) and the pellet (nuclei) was lysed in buffer B (25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, and 10% glycerol as described previously (Thormodsson et al., 1995; Saura et al., 2004) . Proteins were quantified with the BCA protein assay kit (Pierce) and resolved by SDS-PAGE and Western blotting. Protein bands were quantified with the ImageJ software within a linear range of detection. The following antibodies were used: rabbit antiCrtc1, CREB, phosphorylated CREB (Ser133), and Nur77 (Cell Signaling Technology); phosphorylated CRTC1 (Ser151; España et al., 2010b); CBP (A-22), BDNF, c-fos (4), rabbit c-myc (A-10), and c-myc (9E10) (Santa Cruz Biotechnology); rabbit APP C-terminal antibody (Saeko; aa 665-695); rabbit ␣APPs antibody (1736; aa 595-611) recognizing specifically cleaved ␣APPs C-terminus; Nurr1, GAPDH, ␤-tubulin and ␣-actin) (AC15) from Abcam, and lamin B1 (Zymed).
Immunohistochemical and immunofluorescence staining. For A␤ staining, sagittal brain paraffin sections (5 m) were deparaffinized in xylene, rehydrated, and incubated with 3% hydrogen peroxide as described previously (España et al., 2010a) . Sections were incubated in 60% formic acid for 6 min to allow antigen retrieval, washed in 0.1 M Tris-HCl, and incubated with anti-A␤ (6E10; 1:1000; Signet) before immunoperoxidase staining and analysis with a Nikon Eclipse 90i microscope. This staining protocol was previously shown to label specifically A␤ in APP transgenic mice (España et al., 2010a) . For Crtc1-myc and Arc staining, floating sections (40 m) were blocked in PBS containing 5% normal goat serum and 0.2% Triton X-100 and incubated with rabbit anti-myc (1:1000) and mouse anti-NeuN (1:2000; Millipore) antibodies or rabbit anti-Crtc1 (1:300) and mouse anti-myc (1:500; 9E10) or anti-Arc (1:100; Ab62142, Abcam) and the Alexa Fluor 488/594-conjugated goat secondary antibodies (1:400; Invitrogen) and Hoechst (1:10,000; Invitrogen). For Crtc1 nuclear translocation analysis, mice were trained in the MWM for 5 d and killed 30 min after training. Mice were deeply anesthetized with pentobarbital (200 mg/kg, i.p.) and intracardially perfused with saline and 4% buffered formaldehyde. Paraffin sections (5 m) were deparaffinized, microwave heated (10 min) in antigen retrieval citrate buffer and incubated with CRTC1 (1:300; Cell Signaling Technology) and MAP2 (1:300; SigmaAldrich) antibodies and Hoechst followed by AlexaFluor 488/594-conjugated goat IgGs. Images (20ϫ; zoom 0.5) of hippocampal subregions (4 sections; n ϭ 5-6/group) were obtained with a Zeiss LSM700 laser scanning microscope. Crtc1 nuclear staining intensity in the selected regions was measured using a sum projection of six Z-sections (1 m)/section). Hoechst labeling was used to assign the region of interest for nuclear Crtc1 staining, whereas 2 m area around the nucleus was considered cytoplasmic. Crtc1 nuclear/cytoplasm intensity ratio was calculated using ImageJ software (v1.47n).
Microarray and bioinformatic analyses. For microarray analyses, nontransgenic control (WT) and APP Sw,Ind mice (n ϭ 3-4/group) were handled and kept in the home cage (naive) or trained in the MWM for five consecutive days and tested in a probe trial 2.5 h later. Trained mice were killed 30 min after the probe trial by cervical dislocation. Hippocampi were dissected on ice, immersed in RNAlater (R) , and stored at Ϫ80°C. RNA was purified using the RNAeasy mini kit (Qiagen) and quality tested by using the Agilent 2100 Bioanalyzer (Agilent Technologies). Total RNA was amplified, reverse-transcribed, and fluorescently labeled with either Cy3-CTP or Cy5-CTP using the Agilent Fluorescent Linear Amplification kit (Agilent Technologies (Smyth, 2005) . The p values correction for multiple testing was performed using Benjamini and Hochberg algorithm (Benjamini and Hochberg, 1995) . Statistical gene changes Ͼ1 or Ͻ Ϫ1 and corrected p values Ͻ 0.05 were considered significant. Mouse microarray data are available at the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-2067. Gene ontology (GO) analysis of mouse microarray data were performed with ClueGO v1.4 (Bindea et al., 2009 ) using the following parameters: enrichment/depletion two-sided hypergeometric statistical test; correction method: Bonferroni; GO term range levels: 3-8; minimal number of genes for term selection: 5; minimal percentage of genes for term selection: 10%; -score threshold: 0.5; general term selection method: smallest p value; group method: ; minimal number of subgroups included in a group: 3; minimal percentage of shared genes between subgroups: 50%. The CREB-regulated transcriptome consisted of 287 genes, which contained CRE sequences and at least a TATA box in their promoter randomly selected from the CREB Target gene database (http://natural.salk. edu/CREB), and 63 confirmed CREB target genes . The CREB gene list was filtered in the whole microarray data according to the above statistical criteria. Heat maps were computed with Mayday software 2. 10 (Battke et al., 2010) . Differentially expressed CREB genes were submitted to an ontology term enrichment analysis using DAVID (Huang da et al. 2009 ). Filters used in the functional annotation clusters were established as follows: Similarity Term Overlap 3, Similarity Threshold 0.50, Initial Group size 5, final Group Membership 5, and Multiple Linkage Threshold 0.70.
Quantitative real-time RT-PCR. Human hippocampal RNA was isolated using a combination of Trizol method (Life Technologies) and the RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. Purified mouse RNA (1 g; RIN Ͼ 8.0) and human RNA (2 g; RIN Ͼ 6.0) were reverse-transcribed and amplified using Power SYBR Green PCR Master Mix (15 l; Invitrogen) in an Applied Biosystems 7500 Fast system. Data analysis was performed by the comparative ⌬Ct method using the Ct values and the average value of PCR efficiencies obtained from LinRegPCR software. Gene expression in mouse samples was normalized to Gapdh or the geometric mean of three of the most stable following genes determined in each experiment: Gapdh, hypoxanthine guanine phosphoribosyl transferase (Hprt), peptidylprolyl isomerase A (Ppia), and ␤-actin or TATA box binding protein (Tbp; Vandesompele et al., 2002) . Human genes were normalized to the geometric mean of GAPDH, ACTB, and PPIA, which were the three more stable genes found from the Human Reference Gene Panel (TATAA Biocenter AB).
Statistical analysis. Statistical analysis was performed using one-way ANOVA and Bonferroni or Student-Newman-Keuls post hoc tests. The behavioral data were analyzed using two-way ANOVA with repeated measures and Scheffé's S for post hoc comparisons by using the SuperA-NOVA program v1.11. Data represent the mean Ϯ SEM. Differences with p Ͻ 0.05 were considered significant.
Results
Altered activity-dependent genes are associated with early memory loss in an AD mouse model To elucidate transcriptional mechanisms underlying early memory loss in AD, we first analyzed pathological and cognitive changes in a ␤-amyloid precursor protein (APP Sw,Ind ) transgenic mouse that develops AD-like pathological changes (Mucke et al., 2000; España et al., 2010a) . APP Sw,Ind transgenic mice show absence of cerebral A␤ staining at 2 months, intracellular A␤ accumulation in the hippocampus at 6 months and amyloid plaques in hippocampus and cortex at 12-18 months (Fig. 1A) . Levels of human APP were similarly increased (Ϸ2-fold) in APP Sw,Ind at 2 months (1 Ϯ 0.15-fold), 6 months (0.96 Ϯ 0.1-fold), and 12 months (1 Ϯ 0.1-fold; Fig. 1B ). To examine ␣-, ␤-, and ␥-secretase-mediated APP processing we performed biochemical analyses of ␣/␤-secretase-derived soluble(s) ␣APPs and APP C-terminal fragments (CTFs). Levels of ␣APPs were similar, whereas APP CTFs were absent, in the hippocampus of APP Sw,Ind mice at 2-12 months of age (Fig. 1B) , indicating increased A␤ but unchanged ␣-, ␤-, and ␥-secretase-mediated APP processing in APP Sw,Ind mice during aging. We next used the MWM test to evaluate hippocampal-dependent spatial memory, a type of memory altered in AD patients at early disease stages (deIpolyi et al., 2007; Laczó et al., 2011) . Two-month-old APP Sw,Ind and control mice showed similar escape latencies during training, as revealed by a statistically significant day effect (two-way ANOVA: F (4,60) ϭ 15.01; p Ͻ 0.0001) but no genotype effect (F (1,60) ϭ 0.31, p Ͼ 0.05), and a significant preference for the target quadrant in the probe trial (quadrant effect, F (3,48) ϭ 9.1, p Ͻ 0.0001) without significant effect of genotype (F (1,48) ϭ 3.45, p Ͼ 0.05; Fig. 1C ; data not shown). By contrast, APP Sw,Ind mice starting at 6 months spent significantly longer latencies during training (two-way ANOVA, genotype effect, 6 months: F (1,70) ϭ 21.2, p Ͻ 0.0001; 12 months: F (1,50) ϭ 59.6, p Ͻ 0.0001, and 18 months: F (1,70) ϭ 41.5, p Ͻ 0.0001; Fig. 1C ; data not shown). APP Sw,Ind mice developed age-dependent long-term spatial memory deficits starting at 6 months as confirmed by significant reduced target quadrant permanencies (genotype effect, F (1,50) ϭ 13.3; p Ͻ 0.001; age effect: F (3,50) ϭ 0.46; p ϭ 0.71) and number of target crossings (genotype effect, F (1,50) ϭ 13.5; p Ͻ 0.001; age effect: F (3,50) ϭ 3.14; p Ͻ 0.03) in the probe test (Fig. 1C) . Groups did not differ in latencies to find the visible platform or swimming speeds ruling out the possibility of visual/motor disturbances in transgenic mice.
To evaluate whether our spatial training protocol was efficient to induce expression of memory-dependent genes, we analyzed by quantitative real-time RT-PCR (qRT-PCR) the levels of activity-dependent CREB target genes, such as c-fos and Bdnf, in basal and trained conditions as previously reported (Guzowski et al., 2001) . Spatial training for 3 or 5 d, but not swimming without spatial cues, induced expression of c-fos and Bdnf (exon IV ) transcripts in the hippocampus and/or neocortex but not the cerebellum ( Fig. 1 D, E ; data not shown). Interestingly, c-fos and Bdnf levels were significantly reduced in APP Sw,Ind mice after spatial training but not in basal conditions starting at 6 months ( Fig.  1D-F ) . By contrast, levels of CREB target genes Egr-1 and Cyr61 were unchanged in naive and trained APP Sw,Ind mice at 2-18 months (Fig. 1F ) . These results suggested altered expression of CREB target genes regulated by spatial training coinciding with early pathological and memory changes in APP Sw,Ind mice.
Altered CREB-dependent transcriptome in APP Sw,ind mice
To identify gene expression changes associated with early memory deficits in AD, we performed genome-wide transcriptome profile analyses by using mouse cDNA microarrays in the hippocampus of 6-month-old nontransgenic (WT) and APP Sw,Ind mice in two distinct experimental situations: nontrained (naive) and spatial trained conditions ( Fig. 2A) . Using a linear regression model and empirical Bayes analysis (using Ϫ1 Ն log2-fold Ն 1 and p Ͻ 0.05 as statistical criteria), we identified 28 genes (17 upregulated and 11 downregulated) of 33,696 transcripts represented on the mouse genome microarray differentially expressed in APP Sw,Ind mice in basal conditions. By contrast, 932 genes (88% downregulated and 12% upregulated) were differentially expressed in APP Sw,Ind mice compared with WT mice after spatial training ( Fig. 2A) . The microarray data are available in the functional genomic database ArrayExpress (www.ebi.ac.uk/arrayexpress; E-MTAB-2067). Gene-annotation enrichment analysis based on ClueGO, a computational tool that integrates GO terms as well as Kyoto encyclopedia of genes and genomes (KEGG)/ BioCarta pathways (Bindea et al., 2009) , revealed a number of functional biological pathways associated with these differentially transcribed genes in trained APP Sw,Ind mice. The biological network with the most significant k score (Ͼ 0.5) contains 164 differentially expressed genes grouped in several functional GO terms. This network is depicted in Figure 2B as functional biological terms represented as nodes of different colors and sizes, which reflect the enrichment significance of the term, as well as the interrelations (indicated by connecting lines according to k score) of functionally related biological groups deregulated in spatial trained APP Sw,Ind mice. Interestingly, 70 genes of this network are included in five principal biological groups: learning, regulation of neurological system, long-term depression, long-term potentiation, and oxidative phosphorylation ( Fig. 2B; Table 1 ). Specifically, the "learning" group is a significant term within the network because it contains five interconnected subgroups (n ϭ number of genes): learning (n ϭ 10), memory (n ϭ 5), learning or memory (n ϭ 12), visual learning (n ϭ 5), and associative learning (n ϭ 7). Notably, AD (KEGG:05010) was the functional term with the largest number of differentially expressed genes of the total of the term (10.53%; n ϭ 20 genes of 190 genes of the term). However, the AD term was not linked to other groups as it was not sharing enough percentage of genes with any other term.
To identify potential CREB target genes differentially expressed after memory training, we filtered in the raw microarray data 350 genes obtained from the CREB target gene database (http://natural.salk.edu/CREB). Selected genes contained CRE promoter sequences localized within 250 base pairs from the TATA box, a distance that is required for robust transcriptional induction (Conkright et al., 2003a; . Whereas gene expression profile was similar between naive control and APP Sw,Ind mice, 49 CREB target genes (45 downregulated and 4 upregulated) were differentially expressed in spatial trained APP Sw,Ind mice ( Fig. 2C; Table 2 ). Functional enrichment analysis using DAVID identified several biological groups associated with these genes including metabolism (15%), cell signaling (14%), cell adhesion (13%), neuronal transmission/plasticity/neuritogenesis (30%), transcriptional regulation (10%), vesicular trafficking (7%), translation (4%), cell survival (4%), and protein degradation (3%). Expression of genes related to synaptic trans- mission and plasticity was validated by qRT-PCR. Thus, Arc, c-fos, neurofilament (Nefl ), nuclear receptor sub 4, 1, and 2 (Nr4a1, Nr4a2), secretogranin II (Scg2), synaptotagmin IV (syt4 ), chromogranin A (Chga), transducer of ErB-2 (Tob1; p ϭ 0.18), Rab2a (10% decrease), and Ptp4a1 (14% decrease) were downregulated in the hippocampus of trained APP Sw,Ind mice at 6 months ( p Ͻ 0.05) but not at 2 months (Fig. 2 D, E) . These results suggested deregulation of a specific CREB-dependent gene program associated with early memory loss in trained APP Sw,Ind mice.
Activity-dependent Crtc1 transcription is deregulated in APP Sw,ind mice
We next investigated the molecular mechanisms underlying differential deregulation of CREB target genes in APP Sw,Ind mice. Biochemical analysis revealed similar levels of phosphorylated (pSer133) and total CREB (WT: 1.0 Ϯ 0.1 vs APP Sw,Ind : 1.2 Ϯ 0.1-fold change) in the hippocampus of 6-month-old naive control and APP Sw,Ind mice ( p Ͼ 0.05; Fig. 3A ). Spatial training similarly enhanced CREB phosphorylation in control (1.8 Ϯ 0.2-fold) and APP Sw,Ind (2.2 Ϯ 0.4-fold) mice (one-way ANOVA, p Ͼ 0.05). Total levels of Crtc1 were similar in naive or trained WT and APP Sw,Ind mice (naive mice, WT: 1.0 Ϯ 0.1 vs APP Sw,Ind : 1.0 Ϯ 0.07-fold change). By contrast, phosphorylated Crtc1 at Ser151, a site that regulates Crtc1 nuclear translocation and transcription (Altarejos et al., 2008; España et al., 2010b) , was significantly increased in naive APP Sw,Ind mice ( p Ͻ 0.02). Interestingly, spatial training significantly decreased Crtc1 phosphorylation in both genotypes, although levels of phosphorylated Crtc1 were significantly higher in APP Sw,Ind mice ( p Ͻ 0.04; Fig.  3A ). Reduced levels of Crtc1, but not CREB, phosphorylated CREB or CBP, were found in nuclear fractions of APP Sw,Ind forebrains (Fig. 3B) . Confocal microscopy analysis revealed a clear increased of Crtc1 in the nucleus of CA3 pyramidal neurons of WT mice after spatial training (nucleus/cytoplasm ratio, trained: 1.25 vs naive: 1.0), whereas nuclear Crtc1 was reduced in trained APP Sw,Ind mice (ϳ1.05; Fig. 3C ). By contrast, Crtc1 nuclear translocation was more diffuse and sparser in dentate gyrus (DG) granular neurons and occurs only in specific CA1 pyramidal neurons in WT but not APP Sw,Ind mice after spatial training (Fig. 3C) .
These results raised the possibility that Crtc1 dysfunction could cause transcriptional changes in APP Sw,Ind mice. To analyze this possibility, we examined whether the above CREB target genes were dependent on Crtc1. In 10 DIV primary neurons, synaptic activity significantly enhanced (ϳ5-to 100-fold) the expression of Arc, c-fos, Nefl, Nr4a1, Nr4a2, Scg2, Syt, and Bdnf, whereas only slightly increased Chga, Tob1, and Cyr61 levels (1.5-fold; Fig. 3D ). A Crtc1 shRNA (España et al., 2010b), which efficiently decreases Crtc1 transcripts (scramble: 100 Ϯ 10% vs Crtc1 shRNA: 23.3 Ϯ 1.7%, p Ͻ 0.0001 by one-way ANOVA) and CREB transcriptional activity (scramble shRNA: 12.5 Ϯ 0.9 vs Crtc1 shRNA: 5.8 Ϯ 0.8-fold, p Ͻ 0.0001 by one-way ANOVA), significantly reduced expression of those genes, whereas barely affected Tob1 and Cyr61 (Fig. 3D) . Interestingly, Crtc1 transcripts were decreased by synaptic activity, suggesting that sustained neuronal activity downregulates Crtc1 expression. Western blotting analysis confirmed increased Nr4a1 (NUR77), Nr4a2 (NURR1), c-Fos, and BDNF proteins in response to neuronal activity and their Crtc1 dependency (Fig. 3E) . ChiP analyses using antibodies against Crtc1 and CREB (positive control) and an irrelevant IgG (negative control) demonstrated that Crtc1 is specifically recruited to the promoter regions of c-fos, Nr4a1, and Nefl but not Cyr61 in an activity-dependent manner, which contrasts with binding of CREB to c-fos, Nr4a1, and Cyr61 promoters independently of stimulus (Fig. 3F ) . Finally, CA3 pyramidal neurons expressing high Crtc1 levels show elevated Arc expression compared with neurons with low or very low Crtc1 (Fig. 3G ).
Crtc1 overexpression rescues amyloid-induced transcriptional and cognitive deficits
The above results suggested that disruption of Crtc1 could mediate early A␤-induced transcriptional and memory deficits. As a proof of concept, we expressed Crtc1-myc in vivo by using AAV Adcy9, Atp1a1, Atp1a2, Calm1, Calm2, Camk2a, Camk2g, Crk, Gna11, Gnao1, Gng10, Gria1, Gucy1b3, Hras1, Itpr1, Jun, Map3k4, Mapk1, Ppp1ca, Ppp2ca, Ppp2cb, Ppp2r2c, Ppp2r5a, Ppp3ca, Ppp3cb, Prkcb, Prkcc, Rpl3, Skp1a, Slc12a2, Tubb3, Vamp2 , Ywhag Significant nongrouped terms None Alzheimer's disease 10.53 0.0002 1110020P15Rik, Apbb1, Apoe, Atp5o, Calm1, Calm2, Capn2, Cox4i1, Cox7a2l, Cox7c, Itpr1, Lpl, Mapk1, Ndufb2, Ndufb8, Ndufc2, Ppp3ca, Ppp3cb, Sdhb, Snca None Spliceosome 11.43 0.0007 Cwc15, Dhx15, Hnrnpk, Hspa8, Lsm4, Lsm5, Ncbp2, Nhp2l1, Prpf19, Sf3a3, Sf3b5, Sfrs7, Snrpb, Snrpb2, Snrpd3, Syf2 None Glutamatergic synapse 10.85 0.004 Adcy9, Dlgap1, Glul, Gnao1, Gng10, Gria1, Itpr1, Mapk1, Ppp3ca, Ppp3cb, Prkcb, Prkcc, Slc1a3, Slc38a1 Gabarap, Gabarapl1, Gabra5, Glul, Gnao1, Gng10, Prkcb, Prkcc, Slc38a1 Genes are grouped according to their biological function as determined by GO analysis of the mouse microarray data using ClueGO v1.4. Associated genes indicates the percentage of changed genes of the total of genes of the term. Relative mRNA levels in the hippocampus of APP Sw,Ind mice compared to nontransgenic control mice after spatial training in the MWM. Relevant genes from microarray hybridizations are listed in each column, with log2-fold changes indicating relative decrease (Ͻ1) or increase (Ͼ1) of mRNA levels in APP Sw,Ind mice compared with controls. Genes are grouped according to their biological pathway and relative gene expression changes. A gene could be assigned to more than one biological function term. Only genes with p Ͻ 0.05 are given.
ANOVA, p Ͻ 0.03). Viral injections were localized in the septal (dorsal) hippocampus since this region is critical for spatial water-maze acquisition and memory (Moser et al., 1995) . AVVCrtc1 injection resulted in stable and long-term (Ͼ1 month) expression of Crtc1-myc mRNA and protein mainly in neurons of CA1 and CA3 pyramidal layers, stratum oriens, and hilus of the DG (Figs. 4A-C , and data not shown). Crtc1-myc overexpression lead to an increase of Crtc1-myc nuclear translocation in AVVCrtc1-myc injected mice (data not shown). The performance of all groups improved significantly during spatial training in the water maze (day 1 vs day 5, p Ͻ 0.001), although the latencies of AAV-GFP-injected APP Sw,Ind mice were significantly higher than the rest of groups (two-way ANOVA, genotype effect: F (3,135) ϭ 10.2; day effect: F (4,135) ϭ 45.6; p Ͻ 0.0001; Fig. 4D ). In the probe test, nontransgenic mice injected with AAV-GFP and AAVCrtc1, and APP Sw,Ind mice injected with AAV-Crtc1 displayed significantly higher occupancies and number of crossings in the target quadrant/platform relative to other quadrants ( p Ͻ 0.001), whereas APP Sw,Ind mice injected with AAV-GFP failed to show such a preference ( p ϭ 0.9; two-way ANOVA, Scheffé's S post hoc test; Fig. 4D ). Notably, Crtc1 gene delivery significantly increased Arc, Nr4a1, Nr4a2, and Syt4 levels in control and APP Sw,Ind mice, which were significantly different from those of AAV-GFP-injected APP Sw,Ind mice, but decreased Chga, Scg2 and Cyr61 or unaffected c-fos, Tob1, and Tbp (Fig. 4E) . These results demonstrated that Crtc1 efficiently ameliorates hippocampal-dependent learning and memory deficits in APP Sw,Ind mice by enhancing the expression of a specific subset of Crtc1 target genes.
CRTC1-dependent transcriptional changes at early AD stages
To investigate changes in CRTC1-dependent genes during the progression of AD pathology, we analyzed gene expression in the hippocampus of 68 individuals pathologically classified as controls (no pathology, n ϭ 16), early (Braak I-II, n ϭ 22), intermediate (Braak III-IV, n ϭ 14), and advanced (Braak V-VI, n ϭ 16) AD pathological cases (Braak et al., 2006 Arc mRNA expression across AD stages (F (3,64) ϭ 4.7, p Ͻ 0.005) with significant reduced levels at early (Braak I-II) and intermediate (Braak III-IV) pathological stages compared with controls (one-way ANOVA, p Ͻ 0.02; Fig. 5A ). Similarly, Nr4a2 levels were downregulated at Braak III-IV and V-VI stages compared with controls ( p Ͻ 0.04; Fig. 5A ). By contrast, Cyr61 and CRTC1 transcripts were not significantly changed during AD pathological progression (Fig. 5A) . Biochemical analysis revealed a reduction of both total and phosphorylated CRTC1 in human hippocampus at Braak IV and V-VI pathological stages (Fig. 5B) . These results indicated dysregulation of CRTC1-dependent transcription associated with decreased CRTC1 levels in human brain at intermediate Braak III-VI pathological stages.
Discussion
Gene expression changes in the brain occur at early AD stages (Blalock et al., 2004; Bossers et al., 2010; Twine et al., 2011) , but whether deregulation of brain transcriptome causes memory deficits in this disease is still unclear. Genome-wide transcriptome analyses revealed significant differences in genes related to neurotransmission, synaptic plasticity, learning/memory, and oxidative phosphorylation in the hippocampus of memory trained APP Sw,Ind mice, whereas AD was the pathway with the highest number of changed genes relative to those of the term. Specifically, a Crtc1-dependent gene program related to synaptic function and plasticity was deregulated at early AD-related pathological and cognitive stages. Agedependent Crtc1 transcriptional changes occurred in brain regions affected by amyloid pathology and essential for memory encoding (i.e., hippocampus), a result consistent with previous reports showing region-, neuropathology-, and age-dependent gene changes in AD (Liang et al., 2010; Twine et al., 2011) . Notably, synaptic genes identified in this study, including secretogranin II, GluA1, neurofilament, synaptotagmin IV, Nr4a1, and Nr4a2 were previously reported to be reduced in AD brains or CSF (Wakabayashi et al., 1999; Ginsberg et al., 2000; Marksteiner et al., 2002) , whereas others, including BDNF and chromogranin A, are altered and may be novel biomarkers at early AD cognitive stages Perrin et al., 2011) . Similarly, Arc and Nr4a2 were significantly reduced in human hippocampus at intermediate AD pathological stages. These changes are consistent with a decline of neurotransmission and plasticity genes coinciding with intraneuronal A␤ at intermediate AD stages (Bossers et al., 2010) . Similarly, Crtc1-dependent gene changes coincided temporally with initial amyloid accumulation and memory deficits in APP Sw,Ind transgenic mice, suggesting a casual link between these events. These transcriptome alterations are likely caused by age-dependent A␤ accumulation since APP, ␣APPs, or APP CTF are unchanged between 2 and 12 months in APP Sw,Ind transgenic mice. Therefore, we propose that changes on Crtc1-dependent genes related to synaptic function and plasticity are associated with early pathological progression and memory deficits in AD.
Our results indicate that neuronal activity and spatial memory training activate a Crtc1-dependent transcriptional program that includes, among others, genes essential for neurotransmission (Scg2, Syt4, Rab2a, Chga), synaptic plasticity and memory (Arc, ronal activity suggesting that a still unknown feedback regulatory mechanism tightly controls Crtc-dependent transcription. The mechanism underlying Crtc1 activation involves Crtc1 dephosphorylation at Ser151, a motif that regulates Crtc1 nuclear translocation and function (España et al., 2010b; Ch'ng et al., 2012) . Crtc1 dephosphorylation seems to regulate the induction or maintenance rather than basal CREB-dependent gene expression since efficient recruitment of Crtc1 to specific CREB gene promoters depends on synaptic activity (Fig. 3F ) . In addition, Crtc1-dependent transcription depends on the specific cellular stimulus and system, which results for instance in modest (0.5-to 4-fold) or high (5-to 100-fold) gene activation by spatial memory or in vitro synaptic stimulation, respectively. Similar to the effect of Crtc1 ShRNA, Nr4a1-2 are reduced by 30 -50% in the hippocampus of Crtc1 Ϫ/Ϫ mice, an experimental model characterized by emotional changes (Breuillaud et al., 2012) . Whether sustained Crtc-dependent transcription in our experimental conditions is due to the remaining 10 -20% Crtc1 expression, the functional redundancy of Crtc2, and/or alternative transcriptional mechanisms need further investigation.
Our findings also provide strong evidence that Crtc1 dysfunction is associated with hippocampal-dependent transcriptome and memory impairments. First, Crtc1-mediated transcriptional changes are evident in the hippocampus of memory trained but not naive APP Sw,Ind mice, which agrees with the genome-wide transcriptome results showing major gene changes after cognitive stimulation. Second, age-related CREB gene changes are specific for genes dependent on Crtc1, whereas genes activated independently of Crtc1 (Cyr61, Egr1, or Tob1; Ravnskjaer et al., 2007; España et al., 2010b) , are unaffected in APP Sw,Ind mice. Although changes in Arc, c-fos, and Nr4a1 were previously observed in APP transgenic mice (Palop et al., 2005; España et al., 2010b) , its contribution to memory loss was unclear. Our results showing that Crtc1 gene transfer efficiently rescued spatial memory impairments by enhancing the expression of specific subset of Crtc1-dependent genes strongly indicate a role of Crtc1 dysfunction on memory deficits at early AD-related stages. Several mechanisms have been proposed to underlie Crtc1 dysfunction in neurons including changes on kinases or phosphatases (i.e., calcineurin), synapse-nuclear translocation, Crtc1 acetylation, or CREB glycosylation (España et al., 2010b; Jeong et al., 2012; Rexach et al., 2012; Ch'ng et al., 2012) . Our results suggest that impaired Crtc1 dephosphorylation at Ser151 and nuclear translocation in the CA1/CA3 hippocampus may result in Crtc1-dependent transcriptional changes. However, we cannot rule out the possibility that altered Crtc1 levels in advanced AD stages or disrupted activation of CREB might also contribute to CREB transcriptional changes in AD (Pugazhenthi et al., 2011) .
Previous studies showed that pharmacological and genetic activation of CREB signaling ameliorate synaptic and memory deficits in AD transgenic mice (Vitolo et al., 2002; Gong et al., 2004; Smith et al., 2009; Caccamo et al., 2010; Yiu et al., 2011) . Similarly, Crtc1 gene transfer reversed early A␤-induced Crtc1 transcriptome changes and spatial memory deficits. Notably, enhancing expression of a specific subset of CREB target genes was sufficient to reverse learning and memory deficits in APP mice. By contrast, Crtc1 overexpression in vivo did not affect c-fos or decreased CREB target genes activated independently of Crtc1, such as Cyr61 and Chga. This differential effect on gene transcription could be due to the preferential binding of Crtc1/CREB to specific Crtc1 target promoters (i.e., Arc, Nr4a1, Nr4a2…) in detrimental of Crtc1-independent CREB promoters (Zhang et al., 2005) , epigenetic changes caused by binding of Crtc1 to the CBP/CREB complex (Ravnskjaer et al., 2007) , and/or a differential timing of RNA polymerase II occupancy over specific promoters and enhancers (Saha et al., 2011) . However, spatial learning and memory were similar in WT mice after Crtc1 delivery, a result that contrasts with enhancement of contextual memory by Crct1 overexpression (Sekeres et al., 2012) . This apparent discrepancy could be due to distinct neural circuits involved in these memory tasks (associative vs spatial) and different gene-delivered vectors (Herpes simplex virus vs adeno-associated virus) targeting different neuronal populations. Finally, synapse loss and dysfunction tightly correlates with cognitive decline at initial AD stages (Terry et al., 1991; Masliah et al., 2001) . Because Crtc1 regulates expression of multiple proteins involved in synaptic morphology, function, and plasticity, our results raise the possibility that Crtc1 dysfunction underlies synapse dysfunction in AD. In conclusion, targeting specifically Crtc1, instead of affecting globally CREB signaling, can represent a novel therapeutic avenue to ameliorate transcriptome, synaptic, and cognitive changes at early AD stages.
